ABEONA THERAPEUTICS INC. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Abeona Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Abeona Therapeutics Inc. Debt-to-equity for the quarter ending June 30, 2024 was 235 %, a 13.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 235 +27.2 +13.1% Jun 30, 2024
Q1 2024 592 +426 +255% Mar 31, 2024
Q4 2023 265 +118 +80.5% Dec 31, 2023
Q3 2023 209 +87.5 +72.2% Sep 30, 2023
Q2 2023 208 +128 +162% Jun 30, 2023
Q1 2023 167 +102 +158% Mar 31, 2023
Q4 2022 147 +90.2 +159% Dec 31, 2022
Q3 2022 121 +70.7 +141% Sep 30, 2022
Q2 2022 79.4 +32.3 +68.6% Jun 30, 2022
Q1 2022 64.6 +22.3 +52.6% Mar 31, 2022
Q4 2021 56.6 +18.6 +49.1% Dec 31, 2021
Q3 2021 50.3 +18.3 +57.1% Sep 30, 2021
Q2 2021 47.1 +13.4 +39.9% Jun 30, 2021
Q1 2021 42.3 +6.02 +16.6% Mar 31, 2021
Q4 2020 38 -0.53 -1.38% Dec 31, 2020
Q3 2020 32 -9.22 -22.4% Sep 30, 2020
Q2 2020 33.7 +3.94 +13.3% Jun 30, 2020
Q1 2020 36.3 +17.7 +95% Mar 31, 2020
Q4 2019 38.5 +28.3 +276% Dec 31, 2019
Q3 2019 41.2 +36.4 +759% Sep 30, 2019
Q2 2019 29.7 +25.2 +556% Jun 30, 2019
Q1 2019 18.6 +13.1 +238% Mar 31, 2019
Q4 2018 10.2 +3.11 +43.7% Dec 31, 2018
Q3 2018 4.8 -4.56 -48.7% Sep 30, 2018
Q2 2018 4.53 -6.83 -60.1% Jun 30, 2018
Q1 2018 5.5 -8.42 -60.5% Mar 31, 2018
Q4 2017 7.12 -9 -55.8% Dec 31, 2017
Q3 2017 9.36 -8.87 -48.7% Sep 30, 2017
Q2 2017 11.4 -8.51 -42.8% Jun 30, 2017
Q1 2017 13.9 -7.67 -35.5% Mar 31, 2017
Q4 2016 16.1 -11.2 -41% Dec 31, 2016
Q3 2016 18.2 -20.9 -53.4% Sep 30, 2016
Q2 2016 19.9 -165 -89.2% Jun 30, 2016
Q1 2016 21.6 +181 Mar 31, 2016
Q4 2015 27.3 +153 Dec 31, 2015
Q3 2015 39.1 +141 Sep 30, 2015
Q2 2015 185 +288 Jun 30, 2015
Q1 2015 -160 -51.3 -47.4% Mar 31, 2015
Q4 2014 -125 -14.5 -13.1% Dec 31, 2014
Q3 2014 -102 +10.5 +9.38% Sep 30, 2014
Q2 2014 -103 +4.56 +4.23% Jun 30, 2014
Q1 2014 -108 -1.62 -1.52% Mar 31, 2014
Q4 2013 -111 -3.3 -3.07% Dec 31, 2013
Q3 2013 -112 -3.1 -2.84% Sep 30, 2013
Q2 2013 -108 +4.68 +4.16% Jun 30, 2013
Q1 2013 -107 +10.2 +8.7% Mar 31, 2013
Q4 2012 -108 Dec 31, 2012
Q3 2012 -109 Sep 30, 2012
Q2 2012 -113 Jun 30, 2012
Q1 2012 -117 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.